Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) To Announce Fourth Quarter And Full-Year 2013 Financial Results And Corporate Update On February 27, 2014
Published: Feb 13, 2014
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, will report fourth quarter and full-year 2013 financial results before the NASDAQ Global Market opens on Thursday, February 27, 2014. Subsequently, at 8:00 a.m., Eastern Time, Chris Garabedian, Sarepta’s president and chief executive officer, and Sandy Mahatme, Sarepta’s chief financial officer, will host a conference call to discuss fourth quarter and full-year financial results and to provide a corporate update.
Help employers find you! Check out all the jobs and post your resume.